Title: 2015 ACVIM Forum Research Abstract Program Document date: 2015_5_27
ID: 3pnuj5ru_663
Snippet: In conclusion, we have developed and validated a high throughput immunoassay that correlates to the LC-MS and accurately quantifies SDMA in biological samples from dogs and cats. Feline chronic kidney disease (CKD) is characterized by chronic tubulointerstitial nephritis, and inflammation contributes to the progression of renal fibrosis. Mesenchymal stem cell (MSC) therapy may reduce intra-renal inflammation and fibrosis following systemic delive.....
Document: In conclusion, we have developed and validated a high throughput immunoassay that correlates to the LC-MS and accurately quantifies SDMA in biological samples from dogs and cats. Feline chronic kidney disease (CKD) is characterized by chronic tubulointerstitial nephritis, and inflammation contributes to the progression of renal fibrosis. Mesenchymal stem cell (MSC) therapy may reduce intra-renal inflammation and fibrosis following systemic delivery and has demonstrated modest effects in feline CKD following intravenous delivery. However, the effects of perinephric MSC delivery have not been evaluated previously. The purpose of the present study was to evaluate the clinical effects of retroperitoneal delivery of MSC in cats with CKD.
Search related documents:
Co phrase search for related documents- intravenous delivery and stem cell: 1
- intravenous delivery and systemic delivery: 1, 2, 3
- kidney disease and modest effect: 1, 2, 3
- present study and previously evaluate: 1
- present study and renal fibrosis: 1, 2
- present study and stem cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46
- present study and systemic delivery: 1, 2, 3, 4, 5
- renal fibrosis and tubulointerstitial nephritis: 1
Co phrase search for related documents, hyperlinks ordered by date